Raymond J. Henley Iii

Array ( [id] => 11992344 [patent_doc_number] => 20170296500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'Uses of Chlorogenic Acid in the Preparation of Medicaments for Treatment of Psoriasis' [patent_app_type] => utility [patent_app_number] => 15/513401 [patent_app_country] => US [patent_app_date] => 2014-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2864 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15513401 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11574610 [patent_doc_number] => 09629851 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'ROCK in combination with MAPK pathway' [patent_app_type] => utility [patent_app_number] => 15/023229 [patent_app_country] => US [patent_app_date] => 2014-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 7 [patent_no_of_words] => 15048 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10333131 [patent_doc_number] => 20150218135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-06 [patent_title] => 'CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/491333 [patent_app_country] => US [patent_app_date] => 2014-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 57386 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14491333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10961379 [patent_doc_number] => 20140364410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'PYRAZOLOPYRIMIDINE COMPOUNDS AS KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/464602 [patent_app_country] => US [patent_app_date] => 2014-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34099 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14464602 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10961431 [patent_doc_number] => 20140364461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-11 [patent_title] => 'METHOD OF TREATING DERMATOLOGICAL DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/451185 [patent_app_country] => US [patent_app_date] => 2014-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20010 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14451185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10940037 [patent_doc_number] => 20140343057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'TREATMENT OF LUPUS, FIBROTIC CONDITIONS, AND INFLAMMATORY MYOPATHIES AND OTHER DISORDERS USING PI3 KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 14/448998 [patent_app_country] => US [patent_app_date] => 2014-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 61125 [patent_no_of_claims] => 146 [patent_no_of_ind_claims] => 47 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14448998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10933235 [patent_doc_number] => 20140336256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-13 [patent_title] => 'METHOD OF TREATING TOURETTE\'S DISORDER WITH GABA-AMINOTRANSFERASE INACTIVATORS' [patent_app_type] => utility [patent_app_number] => 14/340749 [patent_app_country] => US [patent_app_date] => 2014-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12615 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14340749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10248505 [patent_doc_number] => 20150133501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-14 [patent_title] => 'ALFENTANIL COMPOSITION FOR THE TREATMENT OF ACUTE PAIN' [patent_app_type] => utility [patent_app_number] => 14/331507 [patent_app_country] => US [patent_app_date] => 2014-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12618 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14331507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11766877 [patent_doc_number] => 09375390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-28 [patent_title] => 'Agricultural compositions comprising renewably-based biodegradable 1,3-propanediol' [patent_app_type] => utility [patent_app_number] => 14/330640 [patent_app_country] => US [patent_app_date] => 2014-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29882 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14330640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10925918 [patent_doc_number] => 20140328938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'Pharmaceutical Compositions Comprising Renewably-Based Biodegradable 1,3-Propanediol' [patent_app_type] => utility [patent_app_number] => 14/330624 [patent_app_country] => US [patent_app_date] => 2014-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29874 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14330624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10121357 [patent_doc_number] => 09155704 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-10-13 [patent_title] => 'More palatable, bioequivalent pharmaceutical composition of carprofen' [patent_app_type] => utility [patent_app_number] => 14/329970 [patent_app_country] => US [patent_app_date] => 2014-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3978 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14329970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9813117 [patent_doc_number] => 20150025062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'HCN INHIBITORS AFFECTING GANGLION CELL FUNCTION AND VISUAL FUNCTION' [patent_app_type] => utility [patent_app_number] => 14/327786 [patent_app_country] => US [patent_app_date] => 2014-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7850 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14327786 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10095797 [patent_doc_number] => 09132092 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-09-15 [patent_title] => 'Pharmaceutical composition of doxycycline' [patent_app_type] => utility [patent_app_number] => 14/326949 [patent_app_country] => US [patent_app_date] => 2014-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4837 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14326949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11113410 [patent_doc_number] => 20160310382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-27 [patent_title] => 'COMPOSITION COMPRISING FERULIC ACID ETHYL ESTER AND ARYL ALKANOL' [patent_app_type] => utility [patent_app_number] => 15/105827 [patent_app_country] => US [patent_app_date] => 2014-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3956 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15105827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9799672 [patent_doc_number] => 20150011617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'COMBINED USE OF AMIDES OF MONO- AND DICARBOXYLIC ACIDS AND SILYMARIN IN THE TREATMENT OF RENAL DISEASES' [patent_app_type] => utility [patent_app_number] => 14/323673 [patent_app_country] => US [patent_app_date] => 2014-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3927 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14323673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10767735 [patent_doc_number] => 20160113891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING ADRENALINE AND CITRIC ACID' [patent_app_type] => utility [patent_app_number] => 14/898573 [patent_app_country] => US [patent_app_date] => 2014-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5279 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14898573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12008578 [patent_doc_number] => 09801876 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-31 [patent_title] => 'Complex granule formulation having improved stability comprising levocetirizine and montelukast' [patent_app_type] => utility [patent_app_number] => 14/898935 [patent_app_country] => US [patent_app_date] => 2014-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6637 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14898935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10790036 [patent_doc_number] => 20160136192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-19 [patent_title] => 'METHODS AND COMPOSITIONS FOR ENHANCING COGNITIVE PERFORMANCE' [patent_app_type] => utility [patent_app_number] => 14/897462 [patent_app_country] => US [patent_app_date] => 2014-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17498 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14897462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10361052 [patent_doc_number] => 20150246057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-03 [patent_title] => 'Metalloporphyrin Neurological Treatments' [patent_app_type] => utility [patent_app_number] => 14/291798 [patent_app_country] => US [patent_app_date] => 2014-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 22777 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14291798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9720931 [patent_doc_number] => 20140256632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'METHODS USEFUL IN THE TREATMENT OF BONE RESORPTION DISEASES' [patent_app_type] => utility [patent_app_number] => 14/285437 [patent_app_country] => US [patent_app_date] => 2014-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3205 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14285437 [rel_patent_id] =>[rel_patent_doc_number] =>)